Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TL
Tilray Brands, Inc. Common Stock
TLRY
Mkt Cap
$448.4M
Volume
2.80M
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TL
TLRY
TL
Tilray Brands, Inc. Common Stock
TLRY
News
·
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Mkt Cap
$474.4M
Volume
2.80M
Next Earnings
N/A
Chart
Financials
Earnings
News
About
Insider
Filings
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
The article compares two major cannabis companies navigating industry challenges. Canopy Growth focuses on premium Canadian cannabis and European medical sales but faces internal control weaknesses and significant losses. Tilray Brands has diversified into beverages and international markets, posting record Q1 revenue of $257M with improving margins. The author recommends Tilray as the better choice due to its larger scale, diversified revenue streams, and clearer path to profitability, though both stocks remain risky investments in a volatile industry.
The Motley Fool · Oct 15, 2026
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
SweetWater Brewing, a craft brewery brand by Tilray Brands, launched a concert sweepstakes giving fans 21+ the chance to win tickets to 2026-2027 AEG concerts at select Georgia venues including Georgia Theatre, The Eastern, Variety Playhouse, and Terminal West. Two winners will be selected with prizes valued at approximately $1,200 each, including concert tickets and travel gift cards. The sweepstakes runs through December 31, 2026.
GlobeNewswire Inc. · Oct 15, 2026
3 Huge Red Flags From Tilray's Q1 Earnings Report
Tilray Brands reported Q1 fiscal 2027 results with concerning fundamentals despite revenue growth. The company's cash burn spiked to $16.5 million (up from $1.3 million year-over-year), core cannabis revenue declined 13%, and operating expenses surged 83%. While top-line growth was driven by acquisitions like BrewDog, organic cannabis business weakness and ballooning costs suggest the stock faces continued headwinds.
The Motley Fool · Oct 12, 2026
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
Canopy Growth and Tilray Brands represent diverging strategies in the cannabis industry. Canopy pursues a lean, brand-focused model with emphasis on U.S. expansion, while Tilray has diversified into craft beverages and wellness products. Both companies reported significant net losses in FY 2026 despite revenue growth, with Tilray showing better financial metrics (higher revenue, lower debt-to-equity ratio, higher gross margin) but greater business complexity. The article suggests Tilray may appeal to diversification-focused investors, while Canopy attracts those betting on pure cannabis growth, though both carry substantial risks.
The Motley Fool · Oct 10, 2026
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
Cronos Group shares rose 17% over three months following better-than-expected Q2 2026 results, with first-half revenues up 49% to $98.2 million driven by Canadian market share gains and international expansion. However, the company faces challenges including potentially unsustainable margin improvements, an Israeli anti-dumping investigation, and intensifying European competition from rivals like Village Farms and Tilray. Analysts maintain a cautious stance with unchanged earnings estimates.
Zacks Investment Research · Oct 9, 2026
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates
Tilray Brands reported a quarterly loss of $0.32 per share, significantly worse than the consensus estimate of $0.19, representing a -68.42% earnings surprise. The company also missed revenue expectations, posting $257.15 million versus the estimate of $262.35 million. With unfavorable estimate revisions, Tilray received a Zacks Rank #5 (Strong Sell) rating and has underperformed the S&P 500 by 58.9% year-to-date.
Zacks Investment Research · Oct 8, 2026
Tilray Brands: Is the Stock a Buy at Less Than $4?
Tilray Brands stock has crashed 60% this year and trades below $4, down 84% from its 52-week high. Despite record revenue of $915 million, the company posted a net loss of $105 million and burned $69 million in cash. The analyst recommends avoiding the stock due to poor growth prospects, a highly competitive Canadian market, and a questionable pivot to beverages that doesn't address fundamental business challenges.
The Motley Fool · Oct 6, 2026
VFF Stock Up 49% in Three Months: Is the Rally Sustainable?
Village Farms International (VFF) shares have surged 49% in three months, driven by 15% cannabis sales growth and expanding 51% gross margins, primarily from strong European exports led by Germany. However, the company faces increasing competition from Tilray and Canopy Growth in European markets, pricing pressure from rising industry supply, and heavy dependence on Germany for export growth. While the company holds a Zacks Rank #3 (Hold), investors should await evidence of successful market diversification before committing to longer-term positions.
Zacks Investment Research · Oct 1, 2026
Tilray Brands Has Lost More Than Half of Its Value in 2026, but Here's the Bullish Case for Taking a Chance on This Highly Risky Stock
Tilray Brands has lost over 50% of its value in 2026 and is down 95% over five years, making it a highly risky investment. However, the bullish case centers on potential U.S. marijuana legalization, which could trigger significant stock appreciation even before full legalization occurs. The company has diversified into beverages and alcohol to position itself for future U.S. market entry. While the stock could surge on legalization discussions similar to Canada's 2018 experience, investors should be aware of substantial risks and uncertainty.
The Motley Fool · Sep 15, 2026
Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What's Holding the Stock Back?
Tilray Brands has achieved record fiscal 2026 revenues of $915 million and successfully diversified beyond marijuana into beverages and wellness products, but the stock remains depressed below $5 due to continued unprofitability (losing $1.09 per share in fiscal 2026) and its tiny $600 million market cap relative to established consumer staples competitors. The company is only suitable for aggressive investors until it demonstrates sustainable profitability.
The Motley Fool · Sep 13, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
TL
TLRY
Tilray Brands, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
TLRY
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any TLRY yet.
Related Tickers
CG
CGC
—
SN
SNDL
—
AC
ACB
—
CR
CRON
—
OG
OGI
—
Earnings